Markus Maulhardt

9PUBLICATIONS
92CO-AUTHORS
Haematological tumoursPredictive and prognostic markersRegenerative medicine (incl. stem cells)Food properties (incl. characteristics and health benefits)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 18, 2026
Loncastuximab tesirine in heavily pretreated patients with large B-cell lymphoma: a German Lymphoma Alliance analysis.

|Sep 11, 2026
Transplantation Strategies in Treatment of Primary Plasma Cell Leukemia in Germany-A Multi-Center Analysis.

|Aug 18, 2026
Treatment sequence with gilteritinib and allogeneic haematopoietic stem cell transplantation in relapsed/refractory FMS-like tyrosine kinase 3 (FLT3)-mutated acute myeloid leukaemia patients: A multicentre real-world study.

|Jul 28, 2026
High-Dimensional Immunophenotyping of Plasma-Derived Small Extracellular Vesicles in Pancreatic Cancer: An Exploratory Proof-of-Principle Study.

|Feb 03, 2026
Predicting adverse events for risk stratification of chemotherapy based stem cell mobilization in multiple myeloma.

F Schwarz, L Levien, M Maulhardt

|Aug 14, 2025
Not All Weight Loss Is Equal: Divergent Patterns and Prognostic Roles in Head and Neck Cancer Versus High-Grade B-Cell Lymphoma.

Judith Büntzel, Gina Westhofen, Wilken Harms

Pageof 2

Frequent Collaborators

5 joint publications

Evgenii Shumilov

3 joint publications

Bastian von Tresckow

2 joint publications

Stefan Wirths

2 joint publications

Judith Büntzel